These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25425262)

  • 1. Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma.
    Lai JP; Conley A; Knudsen BS; Guindi M
    Histopathology; 2015 Oct; 67(4):442-50. PubMed ID: 25425262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation.
    Zen C; Zen Y; Mitry RR; Corbeil D; Karbanová J; O'Grady J; Karani J; Kane P; Heaton N; Portmann BC; Quaglia A
    Liver Transpl; 2011 Aug; 17(8):943-54. PubMed ID: 21491582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.
    Rhee H; Nahm JH; Kim H; Choi GH; Yoo JE; Lee HS; Koh MJ; Park YN
    Mod Pathol; 2016 Sep; 29(9):1038-49. PubMed ID: 27312064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation.
    Zeng Z; Ren J; O'Neil M; Zhao J; Bridges B; Cox J; Abdulkarim B; Schmitt TM; Kumer SC; Weinman SA
    BMC Cancer; 2012 Dec; 12():584. PubMed ID: 23216644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells in hepatocellular carcinoma--an immunohistochemical study with histopathological association.
    Matthai SM; Ramakrishna B
    Indian J Med Res; 2015 Oct; 142(4):391-8. PubMed ID: 26609030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.
    Nishihara Y; Aishima S; Kuroda Y; Iguchi T; Taguchi K; Asayama Y; Taketomi A; Kinukawa N; Honda H; Tsuneyoshi M
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1860-8. PubMed ID: 18823434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma.
    Kim M; Hui KM; Shi M; Reau N; Aloman C
    Hepatol Commun; 2022 Nov; 6(11):3247-3259. PubMed ID: 36097402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition.
    Ledaki I; McIntyre A; Wigfield S; Buffa F; McGowan S; Baban D; Li JL; Harris AL
    Oncotarget; 2015 Aug; 6(23):19413-27. PubMed ID: 26305601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness.
    Park H; Lee Y; Lee K; Lee H; Yoo JE; Ahn S; Park YN; Kim H
    Pathol Oncol Res; 2021; 27():604600. PubMed ID: 34257565
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.
    Ellingsen C; Andersen LM; Galappathi K; Rofstad EK
    BMC Cancer; 2015 Oct; 15():805. PubMed ID: 26502718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI features of hepatocellular carcinoma expressing progenitor cell markers.
    Jeong HT; Kim MJ; Kim YE; Park YN; Choi GH; Choi JS
    Liver Int; 2012 Mar; 32(3):430-40. PubMed ID: 22097930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma.
    Sciarra A; Ronot M; Di Tommaso L; Raschioni C; Castera L; Belghiti J; Bedossa P; Vilgrain V; Roncalli M; Paradis V
    Liver Int; 2015 Nov; 35(11):2466-73. PubMed ID: 25865109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study.
    Nahm JH; Rhee H; Kim H; Yoo JE; San Lee J; Jeon Y; Choi GH; Park YN
    Oncotarget; 2017 Nov; 8(59):99359-99371. PubMed ID: 29245907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
    Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
    Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinodular ductular reaction/epithelial cell adhesion molecule loss in small hepatic nodules.
    Zhang Q; Zhang CS; Xin Q; Ma Z; Liu GQ; Liu BB; Wang FM; Gao YT; Du Z
    World J Gastroenterol; 2014 Aug; 20(31):10908-15. PubMed ID: 25152593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy.
    Farris AB; Dursun N; Dhanasekaran R; Coban I; McIntosh EB; Adsay NV; Kim HS
    Pathol Res Pract; 2012 Jan; 208(1):15-21. PubMed ID: 22088254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
    Tan EY; Yan M; Campo L; Han C; Takano E; Turley H; Candiloro I; Pezzella F; Gatter KC; Millar EK; O'Toole SA; McNeil CM; Crea P; Segara D; Sutherland RL; Harris AL; Fox SB
    Br J Cancer; 2009 Jan; 100(2):405-11. PubMed ID: 19165203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
    Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
    Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
    Chan AW; Tong JH; Chan SL; Lai PB; To KF
    Histopathology; 2014 Jun; 64(7):935-50. PubMed ID: 24506513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
    Capkova L; Koubkova L; Kodet R
    Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.